Ofatumumab (Kesimpta): MS Clinical Trials

18 active multiple sclerosis clinical trials involve Ofatumumab (Kesimpta), 7 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.

Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.

Active Ofatumumab (Kesimpta) MS trials

MS trials by therapy